Related references
Note: Only part of the references are listed.Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
Chad C. Bjorklund et al.
LEUKEMIA (2020)
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E. Matyskiela et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The Ikaros family in lymphocyte development
Beate Heizmann et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Zinc finger protein 91 positively regulates the production of IL-1 beta in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome
Chunliu Mi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus
Peter H. Schafer et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity
Yumi Nakayama et al.
JOURNAL OF IMMUNOLOGY (2017)
Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
C. C. Bjorklund et al.
BLOOD CANCER JOURNAL (2015)
Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
Anita K. Gandhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Ikaros Imposes a Barrier to CD8+ T Cell Differentiation by Restricting Autocrine IL-2 Production
Shaun O'Brien et al.
JOURNAL OF IMMUNOLOGY (2014)
Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
Jan Kroenke et al.
SCIENCE (2014)
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Gang Lu et al.
SCIENCE (2014)
Polysaccharide-specific B cell responses to vaccination in humans
Ruth Mitchell et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology
Jordan S. Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Aiolos promotes TH17 differentiation by directly silencing Il2 expression
Francisco J. Quintana et al.
NATURE IMMUNOLOGY (2012)
The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity
Liza B. John et al.
MOLECULAR IMMUNOLOGY (2011)
Immunization Responses in Rheumatoid Arthritis Patients Treated With Rituximab Results From a Controlled Clinical Trial
Clifton O. Bingham et al.
ARTHRITIS AND RHEUMATISM (2010)
Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes
Rajan M. Thomas et al.
JOURNAL OF IMMUNOLOGY (2007)
Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific
G Di Genova et al.
BLOOD (2006)